A control siRNA with random sequence was used as negative control

A control siRNA with random sequence was used as negative control. cyclin D1 and Filamin A co-immunoprecipitate and that lower levels of cyclin D1 are associated with decreased phosphorylation of FLNa at serine 2152 and 1459. We also identify many proteins related to cytoskeletal function, biomolecular synthesis, organelle biogenesis, and calcium regulation whose levels of expression change concomitant with decreased cell motility induced by decreased cyclin D1 and cyclin D1-cdk4/6 activity. == Introduction == The canonical function of cyclin D1 is to CREB4 promote progression through the G1-S phase of the cell cycle through binding to cyclin dependent kinase 4 (cdk4) to phosphorylate and inactivate the retinoblastoma protein and release E2F transcription factors. Several human cancers, including breast, colon and prostate, and hematopoietic malignancies, over-express the cyclin D1 gene (13). However, there is no correlation between cyclin D1 over-expression and regulation of E2F target genes by microarray analysis nor between cdk-dependent cyclin D1 activity and tumor development, suggesting that the role of cyclin D1 in oncogenesis is at least partially independent of its function as a cell cycle regulator (4,5). Cyclin D1 has recently been associated with cell adhesion and motility in primary bone macrophages (6). Studies in cyclin D1/mouse embryo fibroblasts revealed that cyclin D1 inhibits Rho-activated kinase II and thrombospondin 1 to promote cell migration (7). The cdk inhibitor p16INK4ahas also been shown to inhibit the migration of erythroleukemia and endothelial cells (8,9). Indeed, p16INK4aco-localized in the ruffles and lamellipodia of migrating endothelial cells together with cyclin D1, cdk4/6, and the v3-integrin machinery. Filamin A (FLNa), a member of the non-muscle actin-binding protein family, is a widely expressed molecular scaffold protein that MKC3946 regulates signaling events involved in cell motility and invasion by interacting with integrins, transmembrane receptor complexes, adaptor molecules, and second messengers (10,11). FLNa has recently been shown to bind cyclin B1/cdk1 in a yeast two-hybrid system using recombinant glutathione S-transferase cyclin B1 protein as bait and a 10.5 day old embryonic mouse library as prey (12). Using truncated recombinant FLNa and cyclin B1 protein fragments, the regions of interaction between FLNa and cyclin B1 was shown to be located within amino acids 140 of cyclin B1 and the FLNa amino-terminal region in repeat 9. In addition to cyclin B1, filamins have been reported to bind with over thirty proteins and because many filamin-interacting proteins are membrane receptors for cell signaling molecules, filamins may be involved in coordinating a variety of signal transduction pathways (13). For example, FLNa MKC3946 has been shown to be a substrate for calcium-calmodulin-dependent kinase II, interacting with F-actin to promote migration of human neck squamous cell carcinoma cells (14). FLNa has also been shown to interact with prostate specific antigen and regulate androgen receptor (15,16). In addition, FLNa has been shown to be a key element in TGF- signaling through its association with SMADs(17) and in A549 lung carcinoma cells undergoing MKC3946 Epithelial-Mesenchymal Transition(18). FLNa has also been associated with a variety of cancers including prostate, melanoma, human bladder cancer, and neuroblastoma (10,19,20). We hypothesized that elevated cyclin D1 facilitates motility in the highly invasive and metastatic MDA-MB-231 breast cancer cell line. Although there are many proteins that have been shown to affect migration and invasion in this cell line, our focus on these molecules is due to the fact that many of the known proteins affect mitogenic signals which effect levels of cyclin D1 and there are several known kinases effecting FLNa and the.